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Objective: To evaluate the effects of perinatal asphyxia on the level of the response to 
transient otoacoustic emissions in infants.
Methods: Otoacoustic emissions in 154 neonates were performed: 54 infants who suffered 
asphyxia at birth, measured by Apgar score and medical diagnosis, and 100 infants without 
risk were compared. Scores less than 4 in the first minute and/or less than 6 in the fifth 
minute were considered as “low Apgar”. Statistical analysis of the data was performed 
using the Kruskal, Wilcoxon, and Mann-Whitney nonparametric tests.
Results: Lower levels of response were observed in transient otoacoustic emission in the 
group that suffered perinatal asphyxia, with significant values for the frequencies 2,000, 
3,000, and 4,000 Hz in the right ear, and 2,000 and 4,000 Hz in the left ear.
Conclusions: The analysis of the intrinsic characteristics of the otoacoustic emissions 
evidenced low performance of outer hair cells in neonates who had perinatal asphyxia, 
which may affect the development of listening skills in this population. 
© 2014 Sociedade de Pediatria de São Paulo. Published by Elsevier Editora Ltda.  
All rights reserved.
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Avaliação dos níveis de resposta das emissões otoacústicas em neonatos com asfixia 
perinatal
Resumo
Objetivo: Avaliar os efeitos da asfixia perinatal sobre os níveis de resposta das emissões 
otoacústicas por estímulo transiente em lactentes.
Métodos: Foi realizado, para comparação, o registro das emissões otoacústicas transien-
tes em 154 neonatos: 54 bebês que sofreram asfixia perinatal, medida pela escala de 
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Apgar e diagnóstico médico ao nascimento, e 100 bebês sem risco. Escores abaixo de 4 
no primeiro minuto e/ou menores que 6 no quinto minuto foram considerados “Apgar 
baixo”. A análise estatística do conjunto de dados foi efetuada utilizando-se os testes 
não paramétricos de Kruskal, Wilcoxon e Mann-Whitney.
Resultados: Foram observados menores níveis de resposta nas emissões otoacústicas 
transientes para o grupo que sofreu asfixia perinatal, com valores estatisticamente sig-
nificantes para as frequências de 2000, 3000 e 4000Hz na orelha direita e 2000 e 4000Hz 
na orelha esquerda.
Conclusão: A análise das características intrínsecas do exame de emissões otoacústicas 
transientes mostrou baixo desempenho das células ciliadas externas em neonatos que 
tiveram asfixia perinatal, o que pode afetar o desenvolvimento das habilidades auditivas 
nessa população.
© 2014 Sociedade de Pediatria de São Paulo. Publicado por Elsevier Editora Ltda. Todos 
os direitos reservados.
Introduction
The Apgar score allows for the evaluation of newborn clini-
cal status and identification of those in need of assistance, 
assessing the risks of perinatal asphyxia.1 It consists of five 
criteria: heart rate, breathing effort, muscle tone, reflex 
irritability, and skin color. Each item is given values ranging 
from 0 to 2; the higher the score, the better the conditions 
at birth.2,3 
This evaluation is performed by the neonatologist in the 
first, fifth, and tenth minute of life. However, perinatal 
asphyxia develops when there is significant tissue hypo-
perfusion and decreased oxygen supply, resulting from sev-
eral etiologies in the peripartum period, which can cause 
neurological lesions and damage cochlear hair cells.2 Apgar 
scores lower than 4 in the first minute and/or less than 6 
in the fifth minute are considered risk factors for hearing 
loss and deserve attention.4 
The first hearing assessment should be performed in the 
hospital nursery, using the otoacoustic emissions test for 
assessing the integrity of outer hair cells.5,6 In most studies 
on hearing screening with otoacoustic emissions, the cri-
terion used to characterize a normal exam is based on the 
presence of response.7 However, for Aidan et al,8 one of the 
criteria to assess the actual status of the inner ear is the 
analysis of the intrinsic characteristics of this examination, 
such as the response magnitude of these emissions.
According to Basseto et al,9 full-term newborns have 
higher response amplitudes when compared to preterm 
newborns. The female gender and the right ear often have 
larger amplitudes.9,10 The use of ototoxic drugs can cause 
lower amplitude response for otoacoustic emissions.11
From the perspective that analysis of the signal/noise 
ratio can provide additional information on the operation 
of outer hair cells, this study aimed to evaluate the levels 
of response to otoacoustic emissions evoked by transient 
stimuli in infants who had perinatal asphyxia. 
Methods
This study was approved by the Research Ethics committee 
of Faculdade de Medicina de Botucatu (FMB) – Universidade 
Estadual Paulista (UNESP), process No. 4156/2012. Data 
were collected at the Center for Rehabilitation of Hearing 
and Communication Disorders (Centro de Reabilitação dos 
Distúrbios da Audição e Comunicação – CERDAC), Hospital 
das Clínicas (HC) FMB-UNESP, from April 2012 to April 
2013. 
The study consisted of a non-concurrent cohort with a 
fixed population. Inclusion criteria were: a) having being 
born in the HC, b) presence of response in the otoacoustic 
emissions test, c) informed consent signed by the parents/
guardians of the neonate. The exclusion criteria were: a) 
middle ear disorders diagnosed by the otorhinolaryngolo-
gist, b) presence of genetic syndromes, c) history of con-
genital infections, and d) use of ototoxic drugs.
For exposed individuals, an Apgar score of less than 4 
in the first minute and/or less than 6 in the fifth minute 
was considered, as they are at risk for hearing loss, and 
this score was deemed “low Apgar”. The medical diagnosis 
of perinatal asphyxia for this group was also taken into 
account. The diagnosis of perinatal asphyxia was consid-
ered by the physician according to the clinical manifesta-
tions of the newborn, and was classified as neurological, 
cardiovascular, respiratory, metabolic, renal, gastrointesti-
nal, or hematological. For those not exposed, only neonates 
with Apgar scores >7 in the first minute were selected for 
comparison.
There was no criterion for sample pairing, but poten-
tial confounders, gestational age, birth weight, and gender 
were tested (Tables 2, 3, and 4, respectively). As there was 
no evidence of significant probable associations with the 
outcome, the association between asphyxia and responses 
to otoacoustic emissions was analyzed without the need 
for correction. 
Regarding the sample size calculation, since this was a 
non-concurrent cohort with a fixed population, no sam-
pling dimension was required in the planning phase, but 
an estimate of test power, which ranged from 60% to 85%, 
depending on the frequency/ear. The power estimates con-
sidered a simple random sample, normality of outcomes, 
type I error of 0.05, and equal standard deviation between 
individuals with and without low Apgar. 
The assessment of transient otoacoustic emissions was 
performed by a speech therapist specialized in audiol-
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gA (weeks)a 39 (37–41)
BW (grams)a 3.281 (2.170–4.610)
a Summary in median, minimum, and maximum;  
GA, gestational age; BW, birth weight
ogy. Responses from both ears were recorded, with the 
infant in a state of post-prandial natural sleep, in their 
mothers’ arms, after 48 hours of life, in a silent room. 
If the infant awoke during the examination, the mother 
or guardian was advised to make the infant sleep again. 
The equipment used in all assessments was OtoRead/
Interacoustics (Interacoustics do Brasil, RJ, Brazil), 
which allows for the recording of responses by introduc-
ing a probe, coupled with a microphone, in the ear canal.
The parameter PASS/FAIL was used as a criterion of 
analysis, described in the equipment protocol, with click 
stimuli, at an intensity of 83 dB peSPL, and six bands of 
frequencies (from 1,500Hz to 4,000Hz) were evaluated. 
Values  that were considered PASS were emissions present 
in a signal/noise ratio of 6 dB in at least three consecu-
tive frequency bands, including the 4,000 Hz band. The 
examination lasted 64 seconds, at most.
The signal/noise ratios considered for the analysis were 
frequencies 2,000; 3,000 and 4,000 Hz in both ears.12 
The values obtained at each frequency were compared 
between groups. Statistical analysis of the data set was 
performed using the nonparametric Kruskal-Wallis test, 
Spearman’s correlation, and the Mann-Whitney test. The 
nonparametric test was used because the probabilis-
tic distribution of the outcome was not identified. The 
descriptive level was highlighted in all tests and a sig-
nificance level of 0.05 (5%) was used to reject the null 
hypothesis.
Results
The study included 154 infants; sample characterization 
regarding gender, mean gestational age, and birth weight 
is shown in Table 1. 
Before the analysis of perinatal asphyxia effect on the 
response level of otoacoustic emissions, the effect of ges-
tational age and birth weight as potential confounders was 
investigated, but no statistical significance was observed 
(Tables 2 and 3).
However, when investigating gender, higher response 
amplitudes were observed for females at 2,000Hz, 
3,000Hz, and 4,000Hz in the right ear, and 3,000Hz in the 
left ear (Table 4).
When comparing infants who suffered perinatal asphyxia 
with those who were healthy, lower response amplitudes 
were observed in individuals exposed to the risk indicator 
for hearing loss in all frequencies, except at 3,000Hz in the 
left ear (Table 5). In this case, the analysis was adjusted in 
relation to gender, as it was a potential confounding factor.
Discussion
One of the current methods to diagnose early hearing loss 
is hearing screening by otoacoustic emissions, which aims 
at identifying infants with possible hearing impairment. Its 
analysis is based on the categorization of responses as pres-
ent or absent,13 but only those considered absent are can-
didates for diagnostic hearing evaluation by other methods, 
except in cases with suspected auditory neuropathy. 
In the study of the amplitude of otoacoustic emissions 
in relation to gender, significantly higher mean amplitudes 
were observed in newborn females, with a predominance 
of the right ear, as reported by other studies.8,14 According 
to cassidy & Ditty,14 higher amplitudes in the examination 
of transient otoacoustic emissions in females when com-
pared to males can be attributed to increased sensitivity 
of the outer hair cells in females. The analysis of the sig-
nal/noise ratio was also studied by other authors, such as 
Jiang et al,15 who observed significantly lower amplitudes 
at frequencies of 1 kHz and 10 kHz in otoacoustic emis-
sion testing by distortion products in neonates with low 
Apgar scores, suggesting cochlear impairment, even with 
the presence of response. The magnitude of the response 
was also shown to be influenced by other risk factors, such 
as hyperbilirubinemia, prematurity, and exposure to oto-
toxic drugs.16-18
These findings demonstrate that it is necessary to bet-
ter investigate the criteria of normal cochlear function, 
especially the pass/fail criterion of emissions, as studies 
in adult individuals have shown loss of cochlear function 
in those exposed to noise and ototoxic medication19-21 long 
before the decrease in psychoacoustic thresholds, a factor 
that is not possible to investigate in the neonatal stage. 
Literature shows that perinatal asphyxia is a major 
cause of failure in the neonatal hearing screening exami-
nation.22,23 However, when analyzing the amplitude of oto-
acoustic emissions, this study observed lower values than 
those found in newborns with no risk indicators for hearing 
loss at birth. This indicates the possibility of damage to 
cochlear cells caused by tissue hypoxia, an information not 
taken into account for the criteria of normal otoacoustic 
emissions. Therefore, these infants should undergo clini-
cal follow-up, as proper development of auditory skills 
depends on the integrity of the peripheral auditory system, 
and thus, parents should be informed. It is believed that 
other tests, such as brainstem auditory evoked potentials 
(BAEPs), already used in the clinical routine in neonates 
with low Apgar scores and electrocochleography, could 
assist in interpreting these findings.
It can be concluded that the analysis of the intrinsic 
characteristics of the transient evoked otoacoustic emis-
sion test showed lower amplitude values, suggesting lower 
performance of outer hair cells in neonates who suffered 
perinatal asphyxia at the frequency bands of 2,000, 3,000, 
and 4,000 Hz for the right ear, and 2,000 and 4,000 Hz for 
the left ear. Newborns that suffered asphyxia require clini-
cal monitoring and electrophysiological and electroacoustic 
assessment to identify possible damage to the cochlea and 
auditory nerve cells, as well as to the development of audi-
tory processing. 
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